1. Home
  2. TH vs AVXL Comparison

TH vs AVXL Comparison

Compare TH & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$8.10

Market Cap

669.5M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.66

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
AVXL
Founded
1978
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
669.5M
397.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TH
AVXL
Price
$8.10
$3.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$13.00
$22.00
AVG Volume (30 Days)
304.5K
2.2M
Earning Date
11-06-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$314,546,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.00
$2.86
52 Week High
$11.10
$14.25

Technical Indicators

Market Signals
Indicator
TH
AVXL
Relative Strength Index (RSI) 50.02 38.39
Support Level $7.93 $3.56
Resistance Level $8.50 $3.82
Average True Range (ATR) 0.24 0.26
MACD -0.08 0.08
Stochastic Oscillator 15.79 27.59

Price Performance

Historical Comparison
TH
AVXL

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: